...AnGes said that Merrill Lynch Japan Securities requested AnGes acquire and cancel the 12,700 stock acquisition rights outstanding from...

...Last month, AnGes canceled its 12,700 remaining stock acquisition rights under a similar deal with Merrill Lynch Japan Securities...

...Warrant exercise Raised: ¥271.8 million ($2.8 million) Shares: 290,000 Shares after offering: 13.6 million Investor: Merrill Lynch Japan Securities...

...completed: 7/4/13 Type: Private placement Raised: ¥37.4 million ($377,250) Shares outstanding prior: 13.3 million Investor: Merrill Lynch Japan Securities...

...billion ($35 million) Shares: 2.5 million Price prior: ¥1,310 Shares outstanding prior: 13.3 million Investor: Merrill Lynch Japan Securities...

...at least ¥3.3 billion ($34.7 million) through the exercise of 2,500 stock acquisition rights by Merrill Lynch Japan Securities...

...at least Y3.3 billion ($34.7 million) through the exercise of 2,500 stock acquisition rights by Merrill Lynch Japan Securities...

...placement Raised: ¥1.2 billion ($11.4 million) Shares: 4,000 Price: ¥287,100 Shares after offering: 153,033 Investor: Merrill Lynch Japan Securities...

...Japanese gene therapy company AnGes MG Inc. (Tokyo:4563) raised Y1.1 billion ($11.2 million) after Merrill Lynch Japan Securities exercised...

...raised: At least ¥5.1 billion ($51.2 million) Price prior: ¥253,600 Shares outstanding prior: 149,033 Investor: Merrill Lynch Japan Securities...